Chronic kidney disease and stroke.
Chronic kidney disease (CKD) is associated with an increased risk of both ischemic and hemorrhagic stroke. In addition to shared risk factors, this higher cerebrovascular risk is mediated by several CKD-associated mechanisms including platelet dysfunction, coagulation disorders, endothelial dysfunction, inflammation, and increased risk of atrial fibrillation. CKD can also modify the effect of treatments used in acute stroke and in secondary stroke prevention. We review the epidemiology and pathophysiology that link CKD and stroke and the impact of CKD on stroke outcomes. Interdisciplinary collaboration between nephrologists, pharmacists, hematologists, nutrition therapists, primary care physicians, and neurologists in providing care to these subjects may potentially improve outcomes.
Duke Scholars
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Urology & Nephrology
- Tissue Plasminogen Activator
- Stroke
- Secondary Prevention
- Renal Replacement Therapy
- Renal Insufficiency, Chronic
- Platelet Aggregation Inhibitors
- Patient Care Team
- Intracranial Hemorrhages
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Urology & Nephrology
- Tissue Plasminogen Activator
- Stroke
- Secondary Prevention
- Renal Replacement Therapy
- Renal Insufficiency, Chronic
- Platelet Aggregation Inhibitors
- Patient Care Team
- Intracranial Hemorrhages
- Hydroxymethylglutaryl-CoA Reductase Inhibitors